JPSIM Journal of Pakistan Society of Internal Medicine J Pak Soc Intern Med 2709-8729 2710-0804 Pakistan Society of Internal Medicine 10.70302/jpsim.v3i4.2268 jpsim.v3i4.2268 Case Report Successful Treatment of Dermatomyositis in an Obese Female Patient Banaras Faizan faizanbanaras958@gmail.com * khan Nisar Ali Saifuddin Zahid Ayesha Ali Qaisar Tahir Muhammad Osama Ayub iTeaching Hospital/Ayub Medical College, Abbottabad, Pakistan *Correspondence: Faizan Banaras (faizanbanaras958@gmail.com) 18 12 2022 2022 3 4 342 344 11 08 2022 03 10 2022 Copyright © 2022 The Author(s) 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Dermatomyositis (DM) is a rare autoimmune illness that impacts youngsters and adults and is one of the idiopathic inflammatory myopathies (IIM) with skin involvement and the musculoskeletal system. Systems like, cardiac, respiratory, and gastrointestinal may additionally be affected up to a smaller degree. The predictable occurrence of DM is fewer than 10 cases per million inhabitants. Polymyositis has similar pathogenesis to dermatomyositis particularly targeting the musculoskeletal system without skin involvement.

 References Greenberg SA, Amato AA. Inflammatory myopathies. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors Harrison’s principles of internal medicine. 20th ed. New York: McGraw-Hill. Bendewald MJ, Wetter DA, Li X, Davis MDP. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population based study in Olmsted county, Minnesota. Arch Dermatol. 2010;146(1):26-30. Femia AN. Dermatomyositis. Medscape. [Updated July 2021, Cited October 2022] AVilable from : [https://emedicine.medscape.com/article/332783-overview]. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine. 1977;56(4):255-86. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971-82. Gao X, Han L, Yuan L, Yang Y, Gou G, Sun H et al. HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population. BMC Dermatol. 2014;14(1):9. Callen JP. Dermatomyositis. Lancet. 2000;355(9197):53-7. Kampylafka EI, Kosmidis ML, Panagiotakos DB, Dalakas M, Moutsopoulos HM, Tzioufas AG. The effect of intravenous immunoglobulin (IVIG) treatment on patients with dermatomyositis: a 4-year follow-up study. Clin Exp Rheumatol. 2012;30(3):397-401.